Robin Roberts, the "Good Morning America" host who returned to work in February following a bone-marrow transplant, was
hospitalized again this week after feeling "under the weather" while on vacation in Key West.
The 52-year-old Roberts suffers from the rare blood disorder MDS, which was reportedly triggered by the chemotherapy drugs she took after was diagnosed with breast cancer in 2007.
In a memo to viewers released Thursday, Roberts discussed her health.
Urgent: Should Obama Ban Guns? Vote in Poll
"Last week, in the middle of my Key West vacation, I began not to feel well. Nothing serious, just under the weather," wrote Roberts. "I contacted my doctors and flew back to NYC. They felt it best to admit me into the hospital for a few days."
Roberts said her doctors did not attribute her most recent health setback to her hectic work schedule, reported USA Today.
"My doctors assured me that this was not because I was working or doing too much, too soon," said Roberts. "It's extremely common, post bone marrow transplant, to have complications. I'm blessed that mine have not been severe."
Roberts said she plans to recoup over the weekend and return to work next week.
Roberts, who co-hosts ABC's "Good Morning America" with George Stephanopoulos, was diagnosed with MDS last June, shortly after the show beat out NBC’s "Today" show in weekly ratings for the first time in 16 years, noted the New York Post.
The diagnosis forced Roberts to take a hiatus from the show in late August in order to undergo the bone marrow transplant, which was donated by her sister Sally-Ann.
When she returned to the show two months ago, President Barack Obama recorded a welcome-back video with the first lady to celebrate her return.
Special: Should the Supreme Court Legalize Gay Marriage? Vote in Urgent Poll.
Most recently, Roberts was featured on the cover of The Hollywood Reporter, which named her one of one of the 35 most powerful people in the media industry.
Related story:
NBC Nixed Robin Roberts Tweet From Ann Curry, Fearing it Would 'Aid the Enemy'